BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17885738)

  • 41. Local glucose metabolism is unaltered in reversible splenial lesion syndrome.
    Zöllner JP; Wichert J; Schubert-Bast S; Hattingen E; Rosenow F; Strzelczyk A
    Eur J Neurol; 2022 Jun; 29(6):1836-1840. PubMed ID: 35124868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversible cytotoxic oedema in the splenium of the corpus callosum related to tetracycline therapy.
    Grühbaum B; Salzer H; Nasel C; Lernbass I
    Pediatr Radiol; 2010 Oct; 40(10):1693-5. PubMed ID: 20689948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Splenial Lesions of the Corpus Callosum: Disease Spectrum and MRI Findings.
    Park SE; Choi DS; Shin HS; Baek HJ; Choi HC; Kim JE; Choi HY; Park MJ
    Korean J Radiol; 2017; 18(4):710-721. PubMed ID: 28670166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient encephalopathy with reversible white matter lesions in children.
    Okumura A; Noda E; Ikuta T; Natsume J; Nagai T; Gotoh Y; Ando T; Fukatsu H
    Neuropediatrics; 2006 Jun; 37(3):159-62. PubMed ID: 16967368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient lesion in the splenium of the corpus callosum in an epileptic patient.
    Mirsattari SM; Lee DH; Jones MW; Blume WT
    Neurology; 2003 Jun; 60(11):1838-41. PubMed ID: 12796545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment-related transient splenial lesion of the Corpus Callosum in patients with neuropsychiatric disorders: a literature overview with a case report.
    Cirnigliaro G; Di Bernardo I; Caricasole V; Piccoli E; Scaramelli B; Pomati S; Villa C; Pantoni L; Dell'Osso B
    Expert Opin Drug Saf; 2020 Mar; 19(3):315-325. PubMed ID: 32063066
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical analysis of reversible splenial lesion syndrome in Chinese adults: A retrospective study of 11 cases.
    Gao X; Feng Q; Arif S; Liaqat J; Li B; Jiang K
    Medicine (Baltimore); 2020 Sep; 99(36):e22052. PubMed ID: 32899066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible focal splenial lesion of the corpus callosum on MR images in a patient with malnutrition.
    Kosugi T; Isoda H; Imai M; Sakahara H
    Magn Reson Med Sci; 2004; 3(4):211-4. PubMed ID: 16093640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.
    Li C; Wu X; Qi H; Cheng Y; Zhang B; Zhou H; Lv X; Liu K; Zhang HL
    Medicine (Baltimore); 2016 Sep; 95(39):e4798. PubMed ID: 27684805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Marchiafava-Bignami disease with favorable development].
    Delangre T; Hannequin D; Clavier E; Denis P; Mihout B; Samson M
    Rev Neurol (Paris); 1986; 142(12):933-6. PubMed ID: 3563243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review.
    Prilipko O; Delavelle J; Lazeyras F; Seeck M
    Epilepsia; 2005 Oct; 46(10):1633-6. PubMed ID: 16190935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversible corpus callosum splenial lesion due to steroid therapy.
    Aksu B; Kurtcan S; Alkan A; Aralasmak A; Oktem F
    J Neuroimaging; 2015; 25(3):501-4. PubMed ID: 24945326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion.
    Winslow H; Mickey B; Frohman EM
    Arch Neurol; 2006 Jan; 63(1):135-7. PubMed ID: 16401747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiology of Corpus Callosum Lesions with Restricted Diffusion.
    Wilson CA; Mullen MT; Jackson BP; Ishida K; Messé SR
    Clin Neuroradiol; 2017 Mar; 27(1):31-37. PubMed ID: 26031431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of fetal cerebral magnetic resonance imaging for the prenatal diagnosis and prognosis of corpus callosum agenesis].
    Rapp B; Perrotin F; Marret H; Sembely-Taveau C; Lansac J; Body G
    J Gynecol Obstet Biol Reprod (Paris); 2002 Apr; 31(2 Pt 1):173-82. PubMed ID: 12016416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
    Takanashi J; Imamura A; Hayakawa F; Terada H
    J Neurol Sci; 2010 May; 292(1-2):24-7. PubMed ID: 20236662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversible diffusion restriction in the splenium of the corpus callosum due to severe hypoglycemia: A case report and literature review.
    Onder H
    J Neuroradiol; 2016 Dec; 43(6):419-421. PubMed ID: 27521057
    [No Abstract]   [Full Text] [Related]  

  • 58. Infarction of the corpus callosum: computed tomography and magnetic resonance imaging.
    Chrysikopoulos H; Andreou J; Roussakis A; Pappas J
    Eur J Radiol; 1997 Jul; 25(1):2-8. PubMed ID: 9248790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy.
    Ko SY; Kim BK; Kim DW; Kim JH; Choe WH; Seo HY; Kwon SY
    Clin Mol Hepatol; 2014 Dec; 20(4):398-401. PubMed ID: 25548747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy-related change of corpus callosum in a young patient with epilepsy.
    Feitová V; Feit J; Krupa P
    Eur Radiol; 2002 Feb; 12(2):345-7. PubMed ID: 11870432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.